These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 11093076)

  • 21. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
    Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
    Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
    Famaey JP
    Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Kwiecień S; Pajdo R; Ptak A; Pawlik M; Hahn E
    Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
    Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
    Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
    Panara MR; Renda G; Sciulli MG; Santini G; Di Giamberardino M; Rotondo MT; Tacconelli S; Seta F; Patrono C; Patrignani P
    J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natriuretic response to increased pressure is preserved with COX-2 inhibitors.
    Gross JM; Dwyer JE; Knox FG
    Hypertension; 1999 Nov; 34(5):1163-7. PubMed ID: 10567199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
    Muscará MN; McKnight W; Asfaha S; Wallace JL
    Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meloxicam inhibits the growth of colorectal cancer cells.
    Goldman AP; Williams CS; Sheng H; Lamps LW; Williams VP; Pairet M; Morrow JD; DuBois RN
    Carcinogenesis; 1998 Dec; 19(12):2195-9. PubMed ID: 9886578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential inhibition by nimesulide of the early and late phases of intravenous- and intracerebroventricular-LPS-induced fever in guinea pigs.
    Steiner AA; Li S; Llanos-Q J; Blatteis CM
    Neuroimmunomodulation; 2001; 9(5):263-75. PubMed ID: 11964521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meloxicam: influence on arachidonic acid metabolism. Part 1. In vitro findings.
    Engelhardt G; Bögel R; Schnitzer C; Utzmann R
    Biochem Pharmacol; 1996 Jan; 51(1):21-8. PubMed ID: 8534264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation.
    Pinheiro RM; Calixto JB
    Inflamm Res; 2002 Dec; 51(12):603-10. PubMed ID: 12558194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.
    Giuliano F; Warner TD
    Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
    Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
    J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of selective vs. non-selective cyclo-oxygenase inhibitors on fetal membrane prostaglandin synthesis.
    Sawdy R; Pan H; Sullivan M; Bennett P
    J Obstet Gynaecol; 2003 May; 23(3):239-43. PubMed ID: 12850850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins.
    Konturek PC; Brzozowski T; Konturek SJ; Taut A; Kwiecien S; Pajdo R; Sliwowski Z; Hahn EG
    Digestion; 1998; 59(4):284-97. PubMed ID: 9693198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central antinociceptive effects of meloxicam on rat spinal cord in vitro.
    Lopez-Garcia JA; Laird JM
    Neuroreport; 1998 Mar; 9(4):647-51. PubMed ID: 9559932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes.
    Tsubouchi Y; Sano H; Yamada R; Hashiramoto A; Kohno M; Kusaka Y; Kondo M
    Eur J Pharmacol; 2000 May; 395(3):255-63. PubMed ID: 10812057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
    Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
    J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of cyclooxygenase-2 inhibitor on acute lung injury].
    Wang J; Mao B; Chen Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jun; 22(6):351-3. PubMed ID: 11775825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.